Compare SCLX & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCLX | KFFB |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1M | 45.0M |
| IPO Year | 2020 | 2004 |
| Metric | SCLX | KFFB |
|---|---|---|
| Price | $5.57 | $5.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 54.6K | 3.7K |
| Earning Date | 04-10-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 109.52 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $30,253,000.00 | $15,000.00 |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | ★ N/A | $37.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $3.01 |
| 52 Week High | $34.27 | $5.66 |
| Indicator | SCLX | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | 62.71 |
| Support Level | $5.48 | $4.23 |
| Resistance Level | $7.77 | $5.65 |
| Average True Range (ATR) | 0.39 | 0.08 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 11.55 | 72.73 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.